BECN1 and breast cancer: To understand docetaxel resistance in MDA-MB-231-pLKO/miR-622 cells by inhibiting miR-30a, we evaluated the impact of anti-miR-30a treatment on beclin 1-mediated autophagy signaling in breast cancer cells transfected with pLKO/miR-622.